chr11-695835-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001042463.3(TMEM80):​c.8C>T​(p.Ala3Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00299 in 1,230,370 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A3P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0032 ( 10 hom. )

Consequence

TMEM80
NM_001042463.3 missense

Scores

3
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.628

Publications

0 publications found
Variant links:
Genes affected
TMEM80 (HGNC:27453): (transmembrane protein 80) Predicted to be involved in non-motile cilium assembly. Predicted to be located in membrane. Predicted to be integral component of membrane. Predicted to be active in ciliary transition zone. [provided by Alliance of Genome Resources, Apr 2022]
DEAF1 (HGNC:14677): (DEAF1 transcription factor) This gene encodes a zinc finger domain-containing protein that functions as a regulator of transcription. The encoded proteins binds to its own promoter as well as to that of several target genes. Activity of this protein is important in the regulation of embryonic development. Mutations in this gene have been found in individuals with autosomal dominant cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
EPS8L2 (HGNC:21296): (EPS8 signaling adaptor L2) This gene encodes a member of the EPS8 gene family. The encoded protein, like other members of the family, is thought to link growth factor stimulation to actin organization, generating functional redundancy in the pathways that regulate actin cytoskeletal remodeling. [provided by RefSeq, Dec 2008]
EPS8L2 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal recessive 106
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0054572225).
BP6
Variant 11-695835-C-T is Benign according to our data. Variant chr11-695835-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2348330.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM80NM_001042463.3 linkc.8C>T p.Ala3Val missense_variant Exon 1 of 5 ENST00000397510.9 NP_001035928.3 Q96HE8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM80ENST00000397510.9 linkc.8C>T p.Ala3Val missense_variant Exon 1 of 5 5 NM_001042463.3 ENSP00000380646.4 Q96HE8

Frequencies

GnomAD3 genomes
AF:
0.00174
AC:
265
AN:
152048
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00290
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00401
AC:
6
AN:
1498
AF XY:
0.00351
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad NFE exome
AF:
0.00423
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00316
AC:
3412
AN:
1078214
Hom.:
10
Cov.:
30
AF XY:
0.00310
AC XY:
1577
AN XY:
509362
show subpopulations
African (AFR)
AF:
0.000568
AC:
13
AN:
22884
American (AMR)
AF:
0.000955
AC:
8
AN:
8374
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
29
AN:
14334
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26464
South Asian (SAS)
AF:
0.00
AC:
0
AN:
20160
European-Finnish (FIN)
AF:
0.000331
AC:
7
AN:
21154
Middle Eastern (MID)
AF:
0.000338
AC:
1
AN:
2956
European-Non Finnish (NFE)
AF:
0.00348
AC:
3194
AN:
918326
Other (OTH)
AF:
0.00367
AC:
160
AN:
43562
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
174
347
521
694
868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00174
AC:
265
AN:
152156
Hom.:
1
Cov.:
33
AF XY:
0.00161
AC XY:
120
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41536
American (AMR)
AF:
0.00131
AC:
20
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10606
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00290
AC:
197
AN:
67936
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00185
Hom.:
0
Bravo
AF:
0.00173

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 30, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.83C>T (p.A28V) alteration is located in exon 1 (coding exon 1) of the TMEM80 gene. This alteration results from a C to T substitution at nucleotide position 83, causing the alanine (A) at amino acid position 28 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TMEM80: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
15
DANN
Uncertain
1.0
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.54
T;T
M_CAP
Uncertain
0.086
D
MetaRNN
Benign
0.0055
T;T
MetaSVM
Benign
-0.66
T
PhyloP100
-0.63
PrimateAI
Uncertain
0.76
T
REVEL
Benign
0.13
Sift4G
Benign
0.55
T;D
Vest4
0.066
MVP
0.088
MPC
0.25
ClinPred
0.10
T
GERP RS
0.49
PromoterAI
-0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.032
gMVP
0.059
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs576304398; hg19: chr11-695835; API